A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
BioNTech SE
BioNTech SE
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
MediLink Therapeutics (Suzhou) Co., Ltd.
Molecular Partners AG
Peking University First Hospital
Radiopharm Theranostics, Ltd
Beijing Biotech
PMV Pharmaceuticals, Inc
VA Office of Research and Development
Bristol-Myers Squibb
Neonc Technologies, Inc.
Tasca Therapeutics
IDEAYA Biosciences
Jacobio Pharmaceuticals Co., Ltd.
Memorial Sloan Kettering Cancer Center
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Washington University School of Medicine
VM Oncology, LLC
GV20 Therapeutics
DualityBio Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
MediLink Therapeutics (Suzhou) Co., Ltd.
Phanes Therapeutics
Marengo Therapeutics, Inc.
Shanghai Public Health Clinical Center
Heronova Pharmaceuticals
Anhui Provincial Hospital
Anhui Provincial Hospital
Chipscreen Biosciences, Ltd.
Sichuan University
Evopoint Biosciences Inc.